[go: up one dir, main page]

MA26648A1 - THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF BONE DISEASES, AND METHOD FOR THEIR PREPARATION. - Google Patents

THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF BONE DISEASES, AND METHOD FOR THEIR PREPARATION.

Info

Publication number
MA26648A1
MA26648A1 MA25622A MA25622A MA26648A1 MA 26648 A1 MA26648 A1 MA 26648A1 MA 25622 A MA25622 A MA 25622A MA 25622 A MA25622 A MA 25622A MA 26648 A1 MA26648 A1 MA 26648A1
Authority
MA
Morocco
Prior art keywords
preparation
treatment
bone diseases
therapeutic combinations
therapeutic
Prior art date
Application number
MA25622A
Other languages
French (fr)
Inventor
Zhu Ke Hua
Li Mei
Codetta Pan Lydia
Duane Thompson David
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA26648A1 publication Critical patent/MA26648A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA25622A 1998-06-16 1999-06-15 THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF BONE DISEASES, AND METHOD FOR THEIR PREPARATION. MA26648A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8942498P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
MA26648A1 true MA26648A1 (en) 2004-12-20

Family

ID=22217565

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25622A MA26648A1 (en) 1998-06-16 1999-06-15 THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF BONE DISEASES, AND METHOD FOR THEIR PREPARATION.

Country Status (29)

Country Link
EP (1) EP1085867A1 (en)
JP (1) JP2002518328A (en)
KR (1) KR20010052817A (en)
CN (1) CN1305378A (en)
AP (1) AP9901581A0 (en)
AR (1) AR018868A1 (en)
AU (1) AU3342099A (en)
BG (1) BG105128A (en)
BR (1) BR9911357A (en)
CA (1) CA2335112A1 (en)
CO (1) CO5070586A1 (en)
EA (1) EA200001189A1 (en)
GT (1) GT199900083A (en)
HR (1) HRP20000857A2 (en)
HU (1) HUP0102395A2 (en)
ID (1) ID26726A (en)
IL (1) IL139587A0 (en)
IS (1) IS5727A (en)
MA (1) MA26648A1 (en)
NO (1) NO20006381D0 (en)
OA (1) OA11569A (en)
PA (1) PA8472101A1 (en)
PE (1) PE20000633A1 (en)
PL (1) PL345064A1 (en)
SK (1) SK18902000A3 (en)
TN (1) TNSN99118A1 (en)
UY (1) UY25557A1 (en)
WO (1) WO1999065488A1 (en)
ZA (1) ZA993973B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004306A3 (en) * 1998-08-06 2000-06-07 Pfizer Products Inc. Estrogen agonists/antagonists
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
CA2420535A1 (en) * 2000-08-30 2002-03-07 Mary Tanya Am Ende Sustained release formulations for growth hormone secretagogues
GEP20094841B (en) * 2001-11-29 2009-11-25 Gtx Inc Prevention and treatment of androgen-deprivation induced osteoporosis
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (en) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
ES2604943T3 (en) 2007-02-09 2017-03-10 Ocera Therapeutics, Inc. Ghrelin receptor macrocyclic modulators and procedures for their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (en) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-I-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate, a method of its preparation, method of THE treatment OF diseases medicated by agonists of estrogen and a pharmaceutical composition
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (en) * 1996-02-28 1997-06-26 Inc Pfizer COMBINED THERAPY FOR OSTEOPOROSIS

Also Published As

Publication number Publication date
JP2002518328A (en) 2002-06-25
HRP20000857A2 (en) 2001-10-31
IS5727A (en) 2000-11-24
AP9901581A0 (en) 1999-06-30
EA200001189A1 (en) 2001-06-25
CA2335112A1 (en) 1999-12-23
ID26726A (en) 2001-02-01
NO20006381L (en) 2000-12-14
IL139587A0 (en) 2002-02-10
OA11569A (en) 2004-07-01
NO20006381D0 (en) 2000-12-14
ZA993973B (en) 2000-12-15
AU3342099A (en) 2000-01-05
PA8472101A1 (en) 2000-09-29
SK18902000A3 (en) 2001-12-03
EP1085867A1 (en) 2001-03-28
BG105128A (en) 2001-11-30
AR018868A1 (en) 2001-12-12
WO1999065488A1 (en) 1999-12-23
PE20000633A1 (en) 2000-07-26
TNSN99118A1 (en) 2005-11-10
BR9911357A (en) 2001-03-13
CN1305378A (en) 2001-07-25
UY25557A1 (en) 2001-01-31
KR20010052817A (en) 2001-06-25
HUP0102395A2 (en) 2001-11-28
PL345064A1 (en) 2001-11-19
CO5070586A1 (en) 2001-08-28
GT199900083A (en) 2000-12-05

Similar Documents

Publication Publication Date Title
HUP9700603A3 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
NO963568D0 (en) Pharmaceutical composition for the treatment of blood coagulation disorders, methods for the preparation thereof and its use
MA26420A1 (en) MIXED PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OSTEOPOROSIS, AND METHOD FOR THEIR PREPARATION.
DE60023043D1 (en) (S, S) reboxetine for the treatment of incontinence
AU2732001A (en) Apparatus and method of treatment of wounds, burns and immune system disorders
DE60023128D1 (en) PYRAZOLECARBOXAMIDE FOR THE TREATMENT OF FATIBILITY AND OTHER DISEASES
PL336788A1 (en) Probucol monoesters in treating circulatory system and inflammatory diseases
AU1227302A (en) System and method for optimizing drug therapy for the treatment of diseases
FI952169L (en) Stable preparation for the treatment of blood coagulation disorders
FR2707882B1 (en) New protein anti-mediator therapeutic kits, preparation process and pharmaceutical compositions containing them.
ATE201992T1 (en) CARBOSTYRIL DERIVATIVE FOR THE TREATMENT OF OPHTHALMOLOGICAL DISEASES
EP0376251A3 (en) An anticoagulant substance obtained from urine
MA26648A1 (en) THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF BONE DISEASES, AND METHOD FOR THEIR PREPARATION.
PT1237562E (en) PROCESS OF PREPARATION OF MYCANYAN EXTRACTS CONTAINING MICANOLIDE AND DIHYDROMICANOLID AND USES IN THE TREATMENT OF PROLIFERATIVE DISEASES
WO1999056666A8 (en) The treatment of sexual dysfunction in certain patient groups
FR2725990B1 (en) WATER-SOLUBLE DERIVATIVES OF EPIPODOPHYLLOTOXIN, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS, AND THEIR USE FOR CANCER TREATMENTS
TR200200278T2 (en) Calcilitic compositions
DE69735417D1 (en) 2,5-DIHYDROXYBENZYLSULFON DERIVATIVES FOR THE TREATMENT OF SEXUAL DISORDERS
DZ3225A1 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF LUNG DISEASES
MA26650A1 (en) OXO-THIA -AZABICYCLOOCTENES, PHARMACEUTICAL PREPARATIONS CONTAINING THEM, AND THEIR USE FOR THE TREATMENT AND PROPHYLAXIS OF INFECTIOUS DISEASES.
MA26652A1 (en) MIXED PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MUSCULOSKLETAL WEAKNESS, AND METHOD FOR THEIR PREPARATION
DZ2544A1 (en) Dosage forms of sertraline and process for their preparation.
FR2614203B1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN DISEASES AND ITS PREPARATION METHOD.
EP0990441A4 (en) MEDICINE FOR THE TREATMENT OF DIABETIC NEPHROPATHY
DE69739190D1 (en) MEDICAMENT FOR THE TREATMENT OF OCULAR CRUSH DISEASES